Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,095 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Depressive symptom trajectories and polygenic risk scores in individuals with an immune-mediated inflammatory disease.
Kowalec K, Salter A, Fitzgerald KC, Patel M, Han J, Lu Y, Bolton JM, Hitchon C, Bernstein CN, Patten S, Graff LA, Marriott JJ, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease. Kowalec K, et al. Among authors: patel m. Gen Hosp Psychiatry. 2022 Jul-Aug;77:21-28. doi: 10.1016/j.genhosppsych.2022.04.005. Epub 2022 Apr 14. Gen Hosp Psychiatry. 2022. PMID: 35461162 Free PMC article.
Prevalence and Risk Factors of Substance Use Disorder in Rheumatoid Arthritis.
Kowalec K, Carney H, Patel M, Hitchon C, Bolton JM, Patten SB, Graff LA, Bernstein CN, Peschken C, Marrie RA; Canadian Institutes of Health Research Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease. Kowalec K, et al. Among authors: patel m. ACR Open Rheumatol. 2021 Dec;3(12):889-896. doi: 10.1002/acr2.11339. Epub 2021 Sep 28. ACR Open Rheumatol. 2021. PMID: 34582128 Free PMC article.
Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies.
Bewersdorf JP, Mi X, Lu B, Kuykendall A, Sallman D, Patel M, Stevens D, Philipovskiy A, Sutamtewagul G, Masarova L, Keiffer G, Verma A, Bhagwat N, Wang M, Moore A, Rager J, Heiser D, Ro S, Hong WJ, Abdel-Wahab O, Stein EM. Bewersdorf JP, et al. Among authors: patel m. Leukemia. 2025 Jan 24. doi: 10.1038/s41375-025-02515-8. Online ahead of print. Leukemia. 2025. PMID: 39856223 No abstract available.
11,095 results
You have reached the last available page of results. Please see the User Guide for more information.